Cite
MLA Citation
Ahmed Omar Kaseb et al.. “Perioperative nivolumab monotherapy versus nivolumab plus ipilimumab in resectable hepatocellular carcinoma: a randomised, open-label, phase 2 trial.” Lancet gastroenterology and hepatology, vol. 7, 2022, pp. 208–218. http://access.bl.uk/ark:/81055/vdc_100150607645.0x000005